Treatment Consideration (CDC, 7/24)

Tecovirimat may be considered for treatment in people infected with Monkeypox virus:

  • With severe disease

  • Who are at high risk of severe disease:

  • With aberrant infections involving accidental implantation in eyes, mouth, or other anatomic areas where Monkeypox virus infection might constitute a special hazard (e.g., the genitals or anus)

TPOXX Access Network (crowdsourced doc managed by different maintainer):

TPOXX Access Network